Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vor Biopharma Inc shares valued at $20,357 were sold by Attar Eyal C. on Jun 03 ’24. At $1.39 per share, Attar Eyal C. sold 14,645 shares. The insider’s holdings dropped to 96,063 shares worth approximately $92220.48 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As published in their initiating research note from Wedbush on July 26, 2022, Vor Biopharma Inc [VOR] has been an Outperform and the price target has been revised to $18. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in late April. As of December 17, 2021, H.C. Wainwright has initiated its “Buy” rating for VOR. Earlier on December 03, 2021, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for VOR stock.
Analyzing VOR Stock Performance
During the last five days, there has been a surge of approximately 11.49%. Over the course of the year, Vor Biopharma Inc shares have dropped approximately -57.39%. Shares of the company reached a 52-week high of $3.1399 on 01/12/24 and a 52-week low of $0.6300 on 09/30/24. A 50-day SMA is recorded $0.8063, while a 200-day SMA reached $1.3547. Nevertheless, trading volume fell to 0.54 million shares from 0.47 million shares the previous day.
Support And Resistance Levels for Vor Biopharma Inc (VOR)
According to the 24-hour chart, there is a support level at 0.9326, which, if violated, would cause prices to drop to 0.9064. In the upper region, resistance lies at 0.9925. The next price resistance is at 1.0262. RSI (Relative Strength Index) is 65.42 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.1429, which suggests the price will decrease in the coming days. Percent R is at 27.78%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
